Literature DB >> 3756826

Metastatic Leydig cell tumor of the testis. Report of three cases and review of the literature.

J L Grem, H I Robins, K S Wilson, K Gilchrist, D L Trump.   

Abstract

Metastatic Leydig cell carcinomas account for less than 0.2% of all testicular cancers, and may be associated with sex hormone production. Leydig cell carcinoma is relatively refractory to radiotherapy and chemotherapy, and median survival of patients with metastatic disease is less than 2 years. Presented are three cases of metastatic Leydig cell cancer, and a review of the literature pertaining to this rare tumor.

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3756826     DOI： 10.1002/1097-0142(19861101)58:9<2116::aid-cncr2820580925>3.0.co;2-x

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


  10 in total

Review 1.  Malignant Leydig cell tumour of the testis: a case report and review of the literature.

Authors:  E Unlüer; D Ozcan; S Altin
Journal:  Int Urol Nephrol       Date:  1990       Impact factor: 2.370

2.  Therapy of gonadal stromal cell testicular tumours.

Authors:  L Farkas; M Baki; C Pusztai
Journal:  Int Urol Nephrol       Date:  1995       Impact factor: 2.370

3.  [Bilateral testicular masses in the scope of adrenogenital syndrome].

Authors:  C Helke; M May; S Stolz; M Seehafer; T Erler; B Hoschke
Journal:  Urologe A       Date:  2003-12       Impact factor: 0.639

Review 4.  Leydig cell tumor in a patient with 49,XXXXY karyotype: a review of literature.

Authors:  Salwan Maqdasy; Laura Bogenmann; Marie Batisse-Lignier; Béatrice Roche; Fréderic Franck; Françoise Desbiez; Igor Tauveron
Journal:  Reprod Biol Endocrinol       Date:  2015-07-10       Impact factor: 5.211

5.  Retroperitoneal lymph node dissection (RPLND) for malignant phenotype Leydig cell tumours of the testis: a 10-year experience.

Authors:  Jane Hendry; Sioban Fraser; Jeff White; Prabhakar Rajan; David S Hendry
Journal:  Springerplus       Date:  2015-01-14

6.  Minimal invasive fixation following with radiotherapy for radiosensitive unstable metastatic spine.

Authors:  Jia-En Chi; Chun-Yee Ho; Ping-Yeh Chiu; Fu-Cheng Kao; Tsung-Ting Tsai; Po-Liang Lai; Chi-Chien Niu
Journal:  Biomed J       Date:  2021-08-24       Impact factor: 7.892

7.  Spinal cord compression by a solitary metastasis from a low grade leydig cell tumour: a case report and review of the literature.

Authors:  Efthimios P Samoladas; Ashraf S Anbar; Jonathan D Lucas; Hlias Fotiadis; Byron E Chalidis
Journal:  World J Surg Oncol       Date:  2008-07-10       Impact factor: 2.754

8.  Testicular Leydig Cell Tumor with Metachronous Lesions: Outcomes after Metastasis Resection and Cryoablation.

Authors:  Julio J Geminiani; Stephen D Marshall; Tammy S Ho; Steven B Brandes
Journal:  Case Rep Urol       Date:  2015-10-07

9.  Mitotane treatment in patients with metastatic testicular Leydig cell tumor associated with severe androgen excess.

Authors:  Vasileios Chortis; Nicholas J Johal; Irina Bancos; Matthew Evans; Kassiani Skordilis; Peter Guest; Michael H Cullen; Emilio Porfiri; Wiebke Arlt
Journal:  Eur J Endocrinol       Date:  2018-01-12       Impact factor: 6.664

Review 10.  Role of GPER-Mediated Signaling in Testicular Functions and Tumorigenesis.

Authors:  Adele Chimento; Arianna De Luca; Marta Claudia Nocito; Paola Avena; Davide La Padula; Lucia Zavaglia; Vincenzo Pezzi
Journal:  Cells       Date:  2020-09-17       Impact factor: 6.600
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.